Retatrutide Shows Significant Weight Loss Compared to Ozempic in New Report | Retatrutide News

Eli Lilly's retatrutide reportedly offers double the weight loss compared to Ozempic, a GLP-1 agonist. This suggests significant potential in obesity tr...
Weight Loss · November 5, 2026